Investigating arsenic susceptibility from a genetic perspective in Drosophila reveals a key role for glutathione synthetase.
Chronic exposure to arsenic-contaminated drinking water can lead to a variety of serious pathological outcomes. However, differential responsiveness within human populations suggests that interindividual genetic variation plays an important role. We are using Drosophila to study toxic metal response pathways because of unrivalled access to varied genetic approaches and significant demonstrable overlap with many aspects of mammalian physiology and disease phenotypes. Genetic analysis (via chromosomal segregation and microsatellite marker-based recombination) of various wild-type strains exhibiting relative susceptibility or tolerance to the lethal toxic effects of arsenite identified a limited X-chromosomal region (16D-F) able to confer a differential response phenotype. Using an FRT-based recombination approach, we created lines harboring small, overlapping deficiencies within this region and found that relative arsenite sensitivity arose when the dose of the glutathione synthetase (GS) gene (located at 16F1) was reduced by half. Knockdown of GS expression by RNA interference (RNAi) in cultured S2 cells led to enhanced arsenite sensitivity, while GS RNAi applied to intact organisms dramatically reduced the concentration of food-borne arsenite compatible with successful growth and development. Our analyses, initially guided by observations on naturally occurring variants, provide genetic proof that an optimally functioning two-step glutathione (GSH) biosynthetic pathway is required in vivo for a robust defense against arsenite; the enzymatic implications of this are discussed in the context of GSH supply and demand under arsenite-induced stress. Given an identical pathway for human GSH biosynthesis, we suggest that polymorphisms in GSH biosynthetic genes may be an important contributor to differential arsenic sensitivity and exposure risk in human populations.
Ortiz
Jorge G Muñiz
JG
Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0524, USA.
Opoka
Robert
R
Kane
Daniel
D
Cartwright
Iain L
IL
D000483:Alleles; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D001151:Arsenic / Q000633:toxicity*; D018053:Arsenites / Q000633:toxicity; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D002872:Chromosome Deletion; D002874:Chromosome Mapping; D004331:Drosophila melanogaster; D005260:Female; D005978:Glutathione / Q000096:biosynthesis; D005981:Glutathione Synthase / Q000235:genetics*; D008297:Male; D018895:Microsatellite Repeats; D034622:RNA Interference; D012330:RNA, Double-Stranded / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014960:X Chromosome / Q000235:genetics
D000975:Antioxidants; D018053:Arsenites; D012330:RNA, Double-Stranded; D005981:Glutathione Synthase; D005978:Glutathione; C015001:arsenite; D001151:Arsenic
J Immunol. 2004 Jan 1;172(1):144-54
14688320
Nature. 2007 Jul 12;448(7150):151-6
17625558
Nat Rev Cancer. 2005 Aug;5(8):626-39
16034367
Genetics. 2002 Jan;160(1):247-56
11805060
Toxicology. 2005 Jul 1;211(1-2):115-23
15863254
Environ Health Perspect. 2006 Mar;114(3):355-9
16507457
Nat Genet. 2004 Mar;36(3):288-92
14981519
J Biol Chem. 2003 Nov 21;278(47):46369-77
12954617
Adv Enzymol Relat Areas Mol Biol. 1999;73:209-67, xii
10218110
Mutat Res. 2008 Jan 1;637(1-2):80-92
17850829
J Biol Chem. 2002 Mar 29;277(13):10795-803
11790780
J Theor Biol. 2006 Feb 21;238(4):919-36
16125728
Cell Mol Life Sci. 2005 Sep;62(17):1938-45
15990954
Environ Health Perspect. 2007 Apr;115(4):636-42
17450236
Toxicol Appl Pharmacol. 2002 Sep 1;183(2):99-107
12387749
Annu Rev Pharmacol Toxicol. 2007;47:243-62
17002598
J Biol Chem. 2002 Jan 11;277(2):1158-65
11698394
J Occup Environ Med. 2006 May;48(5):478-88
16688004
Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6053-8
11972053
Arch Toxicol. 2005 Apr;79(4):183-91
15526190
Genome Res. 2001 Jun;11(6):1114-25
11381037
Toxicol Sci. 2005 Oct;87(2):365-84
16014739
Mutat Res. 2003 Dec 10;533(1-2):37-65
14643412
Environ Health Perspect. 1998 Jun;106(6):355-9
9618352
Nat Rev Genet. 2005 Jan;6(1):9-23
15630418
J Biol Chem. 2004 Jul 30;279(31):32700-8
15161912
Environ Res. 2003 Jun;92(2):85-91
12854687
Environ Pollut. 2002;118(1):19-28
11996379
Mutat Res. 1997 Jun;386(3):197-207
9219558
Methods. 2001 Dec;25(4):402-8
11846609
Int J Epidemiol. 1998 Oct;27(5):871-7
9839746
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6499-503
10823906
Eur J Pharmacol. 1995 Dec 7;293(4):455-62
8748699
Chem Res Toxicol. 2001 Aug;14(8):1051-7
11511179
J Biomed Biotechnol. 2008;2008:597913
18629230
Toxicol Appl Pharmacol. 2004 Aug 1;198(3):319-26
15276411
Toxicology. 2002 Jan 15;170(1-2):55-62
11750083
Environ Health Perspect. 2005 Jun;113(6):775-81
15929903
Environ Health. 2007 Feb 06;6:5
17284320
Nature. 2003 Dec 18;426(6968):789-96
14685227
Chem Res Toxicol. 2003 Dec;16(12):1507-13
14680363
Anal Biochem. 2000 Apr 10;280(1):80-6
10805524